SPIEGELMAN DANIEL K 4
4 · MYRIAD GENETICS INC · Filed Jun 4, 2024
Insider Transaction Report
Form 4
SPIEGELMAN DANIEL K
Director
Transactions
- Sale
Common Stock
2024-06-03$22.04/sh−3,788$83,488→ 36,705 total - Sale
Common Stock
2024-06-04$22.05/sh−3,788$83,525→ 32,917 total
Footnotes (1)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.